IBS Treatment Market Outlook:
IBS Treatment Market size was over USD 3.29 billion in 2025 and is poised to exceed USD 7.58 billion by 2035, witnessing over 8.7% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of IBS treatment is estimated at USD 3.55 billion.
The rise in sedentary lifestyles and poor eating habits are some of the major reasons boosting the prevalence rates of irritable bowel syndrome, which is subsequently driving high demand for IBS treatment solutions. For instance, the International Foundation for Gastrointestinal Disorders (IFFGD) estimates that around 5 % to 10% of the population around the globe are living with irritable bowel syndrome issues. Around 20% to 40% of visits to gastrointestinal clinics are due to irritable bowel syndrome issues.
The rising awareness programs and increasing research funding are leading to the development of advanced irritable bowel syndrome therapeutic drugs. Globally, April is commemorated as irritable bowel syndrome awareness month. Several hospitals and clinics run free diagnosis and awareness campaigns during this period. Such initiatives are set to fuel the irritable bowel syndrome treatment market growth in the coming years.
